Bostankolu Değirmenci, B. Et Al. 2022. The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients. The 48 th Annual Meeting of the European Blood and Marrow , (Praha, Czech Republic), 362-363.

Bostankolu Değirmenci, B., Yegin, Z. A., Dikyar, A., Aydın Kaynar, L., Özkurt, Z. N., Uyar Göçün, F. P., ... Akyürek, N.(2022). The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients . The 48 th Annual Meeting of the European Blood and Marrow (pp.362-363). Praha, Czech Republic

Bostankolu Değirmenci, BAŞAK Et Al. "The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients," The 48 th Annual Meeting of the European Blood and Marrow, Praha, Czech Republic, 2022

Bostankolu Değirmenci, BAŞAK B. Et Al. "The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients." The 48 th Annual Meeting of the European Blood and Marrow , Praha, Czech Republic, pp.362-363, 2022

Bostankolu Değirmenci, B. Et Al. (2022) . "The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients." The 48 th Annual Meeting of the European Blood and Marrow , Praha, Czech Republic, pp.362-363.

@conferencepaper{conferencepaper, author={BAŞAK BOSTANKOLU DEĞİRMENCİ Et Al. }, title={The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients}, congress name={The 48 th Annual Meeting of the European Blood and Marrow}, city={Praha}, country={Czech Republic}, year={2022}, pages={362-363} }